University of Arizona, Department of Pediatrics (Cardiology), 1501 N. Campbell Ave, P.O. Box 245073, Tucson AZ, 85724 USA.
J Invasive Cardiol. 2021 Apr;33(4):E259-E262. doi: 10.25270/jic/20.00445. Epub 2021 Mar 3.
Pulmonary vein stenosis (PVS) is aggressive, with high morbidity and mortality. Surgical and catheter interventions yield modest success, at best. Refinements in catheter interventions could potentially improve outcomes in this patient population. The goal of this study was to determine the utility of intravascular ultrasound (IVUS) for patients with congenital heart disease and PVS.
Single-center, retrospective review of patients with congenital heart disease and PVS undergoing diagnostic or interventional catheterizations from March 2015 to February 2020. IVUS of the pulmonary veins was performed using an Eagle Eye Platinum IVUS catheter (Volcano Corporation).
Five patients underwent 6 procedures (2 diagnostic, 4 interventional). Median age was 1.5 years (range, 0.7-47.5 years) and weight was 8.8 kg (range, 7.3-61 kg). For the interventional procedures, mean pulmonary vein gradient was 8.7 mm Hg with reduction to 1.1 mm Hg (P<.001). Four patients had congenital PVS and 1 patient was post repair of Scimitar syndrome with an obstructed pulmonary venous baffle. Use of IVUS allowed confirmation of stent expansion and apposition, interval vessel growth after initial stenting, and detection of long-segment hypoplasia, unlikely to respond to intervention. There were no thrombotic complications related to IVUS use.
IVUS of the pulmonary veins is safe and easy to perform, and provides detailed imaging of PVS to help guide therapy. For those requiring intervention, adequate stent apposition to the pulmonary vein walls, as well as limiting vessel overdilation, may minimize future in-stent stenosis and need for reintervention in this challenging disease.
肺静脉狭窄(PVS)具有侵袭性,发病率和死亡率高。手术和导管介入的效果充其量也只是适度。导管介入的改进有可能改善这一患者群体的预后。本研究的目的是确定血管内超声(IVUS)在先天性心脏病和 PVS 患者中的应用价值。
对 2015 年 3 月至 2020 年 2 月期间因先天性心脏病和 PVS 而行诊断性或介入性导管检查的单中心回顾性研究。使用 Eagle Eye Platinum IVUS 导管(Volcano Corporation)对肺静脉进行 IVUS 检查。
5 例患者行 6 次手术(2 次诊断性,4 次介入性)。中位年龄为 1.5 岁(范围 0.7-47.5 岁),体重为 8.8kg(范围 7.3-61kg)。介入性手术时,平均肺静脉梯度为 8.7mmHg,降至 1.1mmHg(P<.001)。4 例为先天性 PVS,1 例为 Scimitar 综合征修复术后肺静脉旁路阻塞。IVUS 的应用可确认支架扩张和贴壁、初始支架置入后间隔血管生长以及检测到长节段发育不良,这些情况不太可能对介入治疗产生反应。IVUS 应用无血栓并发症。
肺静脉 IVUS 安全且易于操作,可提供详细的 PVS 成像,有助于指导治疗。对于需要介入治疗的患者,支架充分贴壁于肺静脉壁,以及限制血管过度扩张,可能会最大限度地减少未来支架内狭窄和该挑战性疾病再次介入治疗的需要。